Suppr超能文献

胰高血糖素样肽-1激动剂艾塞那肽-4可减弱大鼠在固定和渐进比率强化程序下对甜味脂肪的自我给药行为。

The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats.

作者信息

Bernosky-Smith Kimberly A, Stanger David B, Trujillo Alexandria J, Mitchell Luke R, España Rodrigo A, Bass Caroline E

机构信息

Department of Biology, D'Youville College, 320 Porter Ave., Buffalo, NY, United States.

Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, 3435 Main St, Buffalo, NY, United States.

出版信息

Pharmacol Biochem Behav. 2016 Mar;142:48-55. doi: 10.1016/j.pbb.2015.12.007. Epub 2015 Dec 15.

Abstract

GLP-1 agonists such as exendin-4 (EX4) are used in the treatment of type-2 diabetes and have the additional benefit of promoting weight loss. GLP-1 agonists decrease feeding through peripheral effects, but recent evidence suggests they may also influence sweet or high fat preference, as well as motivation to obtain these tastants. Yet it remains unclear how GLP-1-induced alterations in food preference influences decreases in overall feeding. The current study sought to determine if EX4 affects the reinforcing strength and consumption of a highly palatable sweet/fat reinforcer. Rats were trained to self-administer sweetened vegetable shortening (SVS) under fixed (FR) and progressive ratio (PR) schedules of reinforcement. EX4 (0.3-2.4μg/kg, i.p.) administered one hour prior to operant sessions significantly reduced responses for SVS under both FR and PR schedules, although the lowest active dose (0.6μg/kg) significantly suppressed FR responding only. EX4 also dose dependently decreased locomotor activity (0.6-2.4μg/kg doses), but did not enhance acute kaolin intake, suggesting that nausea did not influence the self-administration results. Analysis of ED50 values show that EX4 is more effective at inhibiting FR responding versus PR, indicating that EX4 may have more potent effects on amount consumed versus motivation for SVS. Although EX4 caused generalized locomotor suppression, these results do not fully explain the decreases in operant responding. For example, a dose of EX4 (0.6μg/kg) that significantly suppressed locomotor activity did not affect the mean total number of lever presses during PR sessions (59±15), although it did significantly reduce lever presses during FR sessions (21±3). In addition, the pattern of intake was constant at the beginning of the sessions in both PR and FR schedules, regardless of the dose. Together these data suggest that EX4 inhibits consumption of a palatable high sweet/high fat reinforcer potentially through altering satiety.

摘要

胰高血糖素样肽-1(GLP-1)激动剂,如艾塞那肽-4(EX4),被用于治疗2型糖尿病,并且还有促进体重减轻的额外益处。GLP-1激动剂通过外周效应减少进食,但最近的证据表明它们可能还会影响对甜味或高脂肪食物的偏好,以及获取这些味觉物质的动机。然而,尚不清楚GLP-1引起的食物偏好改变如何影响总体进食量的减少。当前的研究旨在确定EX4是否会影响一种高度可口的甜味/脂肪强化物的强化强度和消耗量。大鼠在固定(FR)和累进比率(PR)强化程序下接受训练,以自我给药甜蔬菜起酥油(SVS)。在操作训练前1小时腹腔注射EX4(0.3 - 2.4μg/kg),在FR和PR程序下均显著降低了对SVS的反应,尽管最低有效剂量(0.6μg/kg)仅显著抑制了FR反应。EX4还剂量依赖性地降低了运动活性(0.6 - 2.4μg/kg剂量),但并未增加高岭土的急性摄入量,这表明恶心并未影响自我给药结果。ED50值分析表明,EX4在抑制FR反应方面比PR更有效,这表明EX4对SVS的消耗量可能比对其动机有更强的作用。尽管EX4引起了全身性的运动抑制,但这些结果并不能完全解释操作反应的减少。例如,一剂显著抑制运动活性的EX4(0.6μg/kg)并未影响PR训练期间的平均总压杆次数(59±15),尽管它确实显著减少了FR训练期间的压杆次数(21±3)。此外,在PR和FR程序的训练开始时,无论剂量如何,摄入模式都是恒定的。这些数据共同表明,EX4可能通过改变饱腹感来抑制可口的高糖/高脂肪强化物的消耗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67ad/5467700/882e122a6984/nihms-829616-f0001.jpg

相似文献

3
Role of lateral septum glucagon-like peptide 1 receptors in food intake.外侧隔区胰高血糖素样肽-1受体在食物摄入中的作用。
Am J Physiol Regul Integr Comp Physiol. 2016 Jul 1;311(1):R124-32. doi: 10.1152/ajpregu.00460.2015. Epub 2016 May 18.

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验